Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-110357
Filing Date
2025-11-12
Accepted
2025-11-12 16:10:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2530735d3_defa14a.htm DEFA14A 775664
2 GRAPHIC tm2530735d3_defa14aimg01.jpg GRAPHIC 18838
  Complete submission text file 0001104659-25-110357.txt   802889
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37990 | Film No.: 251472783
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)